期刊文献+

组织因子siRNA表达载体的构建及其抑制人神经母细胞瘤细胞组织因子表达的研究 被引量:2

Construction of TFsiRNA Expression Vector and Study on Its Inhibitive Effect in Human Neuroblastoma
下载PDF
导出
摘要 目的:构建组织因子(TF)特异性小干扰RNA(siRNA)表达载体,观察其对人神经母细胞瘤细胞TF表达的影响。方法:分子生物学方法构建TFsiRNA-pSUPER表达载体,限制酶切予以初步筛选,基因测序进行证实。以脂质体Lipo-fectamine2000介导转染人神经母细胞瘤细胞系SK-N-MC。以WesternBlotting检测TF表达。结果:所构建TFsiRNA-pSUPER表达载体经基因测序证实。SK-N-MC细胞高表达TF,TFsiRNA-pSUPER表达载体转染48h后,TF表达水平与转染pSUPER质粒的对照细胞相比显著降低,呈剂量依赖性。结论:人神经母细胞瘤SK-N-MC中TF异常高表达,本研究构建的TFsiRNA表达载体可在SK-N-MC中特异性下调TF表达,可作为干预TF表达、研究其非凝血功能的有效手段。 Objective:To construct the specific tissue factor(TF)small interfering(siRNA)expressive vector and study the regulative effect on TF expression in human neuroblastoma cells.Method:TFsiRNA-pSUPER plasmid was construscted by inserting specific 19-nt silencing sequence targeting TF gene into pSUPER vector.Potential construct were screened by restrictive enzyme digestion reaction and then identified by gene sequencing.Transfection of TFsiRNA-pSUPER was performed by using lipofectamine2000.The expression of TF was examined by Western blotting.Results:The constructed TFsiRNA-pSUPER was identified by gene sequencing.Human neuroblastoma cell line SK-N-MC expressed high level of TF.Knockdown of TF expression was achieved by transfection of TFsiRNA-pSUPER on SK-N-MC cells in a dose-deqendent manner.Conclusion:These results suggest that TFsiRNA-pSUPER has been constructed successfully and can knockdown TF in high TF-expressive human neuroblastoma cell line SK-N-MC.TFsiRNA-pSUPER can be used as a potential means of inhibition of TF expression especially while studying its non-coagulative function.
出处 《微循环学杂志》 2007年第3期16-18,共3页 Chinese Journal of Microcirculation
基金 卫生部临床重点学科资助项目(卫规财发【2004】468号)
  • 相关文献

参考文献8

  • 1Versteeg HH, Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost, 2006,32 ( 1 ) : 24-32.
  • 2方峻,魏文宁,夏凌辉,宋善俊.TF-F Ⅶa复合物影响人卵巢癌细胞尿激酶型纤溶酶原激活物受体mRNA表达的研究[J].中华血液学杂志,2004,25(3):143-146. 被引量:19
  • 3Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science,2002,296(5567) :550-553.
  • 4Holen T, Amarzguioui M, Wiiger MT, et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res, 2003,31 (9) : 1 757 - 1 766.
  • 5Holen T, Amarzguioui M, Babaie E, et al. Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res, 2002,30 (8):2 401-2 407.
  • 6Putral LN, Gu W, MeMillan NA. RNA interference for the treatment of cancer. Drug News Perspect,2006,19(6) :317- 324.
  • 7方峻,魏文宁,夏凌辉,宋善俊.组织因子/活化因子Ⅶ复合物影响人卵巢癌细胞侵袭及转移能力的研究[J].中华血液学杂志,2004,25(9):523-527. 被引量:9
  • 8Forster Y, Meye A, Albrecht S,et al. Tissue factor and tumor: clinical and laboratory aspects. Clin Chim Acta, 2006,364 (1-2): 12-21.

二级参考文献9

共引文献23

同被引文献29

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部